Expecting 18-20% growth for FY11: Ipca Labs

  • 5:02
  • Published On: June 02, 2010
Cinema View
Embed
AK Jain, executive director at Ipca Laboratories, says for FY10 the company had posted 22 per cent and for this fiscal it expects growth of 18-20 per cent. The company has seen strong growth in CVS, anti-diabetic, pain management therapies.

Related Videos

Taj Group Enters Luxury Residences Business. First Project In Chennai
May 16, 2024 6:57
Rakesh Jhunjhunwala's Wife Loses Rs 800 Crore As Her Biggest Stock Bet Tanks
May 08, 2024 1:06
Meet The Woman Who Built Her Six-Figure Food Business After Getting Laid Off
May 01, 2024 7:46
Drugs Worth Rs 600 Crore, 14 Pakistanis Caught In Massive Op On The Sea
April 28, 2024 1:06
Kutch's Textile Craft Ajrakh Gets Geographical Indication Tag
April 28, 2024 2:31
What Does Launch Of Derivative Contracts On Nifty Next 50 Mean For You?
April 24, 2024 5:51
"Tesla Factory In India Will Be Game-Changer": Ex-Chief Economic Advisor To NDTV
April 18, 2024 5:10
Sensex Crosses 75,000-Mark In Historic Milestone For Share Market
April 09, 2024 3:36
Explained: How Climate Change Poses A Health Risk To India
March 24, 2024 18:15
Probe Agency Conducts Raids In Fake Cancer Drugs Case, Recovers Rs 65 Lakh
March 18, 2024 2:34
"Can Identify Fake Medicines Through Barcode": Doctor
March 17, 2024 1:57
"Effect Of Substandard Medicine Can Be Death": Expert
March 17, 2024 1:34
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination